Increased LGALS1 expression in cancer cells such as lung, liver, ovarian, glioblastoma, and lymphoma has been associated with drug resistance (temozolomide, sorafenib, rituximab, and cisplatin) [149,150,151,152,153,154,155,156]. The gene discussed is LGALS1; the disease is glioblastoma.